目的评价中文版8条目Morisky用药依从性问卷(MMAS-8)评估2型糖尿病患者用药依从性的信效度。方法纳入老年2型糖尿病患者127例,采用中文版MMAS-8及用药依从性视觉模拟评分(MA-VAS)评估,采用信度分析、相关分析、两样本t检验及因子分析评...目的评价中文版8条目Morisky用药依从性问卷(MMAS-8)评估2型糖尿病患者用药依从性的信效度。方法纳入老年2型糖尿病患者127例,采用中文版MMAS-8及用药依从性视觉模拟评分(MA-VAS)评估,采用信度分析、相关分析、两样本t检验及因子分析评价量表信效度。结果中文版MMAS-8的Cronbachα系数为0.60,组内相关系数(ICC)为0.78。结构分析共提取3个公因子,共解释总方差的55.2%。中文版MMAS-8评分与MA-VAS评分相关(r=0.75,P<0.001)。血糖达标组〔糖化血红蛋白(Hb A1c)≤7%〕的中文版MMAS-8评分比血糖未达标组(Hb A1c>7%)高(7.1±1.0 vs 5.9±1.5,t=-4.31,P<0.001),两组间用药依从性差异显著(χ2=20.190,P<0.001)。结论中文版MMAS-8信效度较好,且简单、可靠、实用,可作为临床工具用于评估2型糖尿病患者的用药依从性。展开更多
Objective: To validate a Greek version of the structured self-reported 8-item Morisky Medication Adherence Scale (MMAS-8) and determine its psychometric properties in patients with chronic illnesses. Methods: A cross-...Objective: To validate a Greek version of the structured self-reported 8-item Morisky Medication Adherence Scale (MMAS-8) and determine its psychometric properties in patients with chronic illnesses. Methods: A cross-sectional survey was conducted in a small public hospital and a public health care centre, in a rural town in western Greece. The sample consisted of 100 patients with various chronic illnesses. Data were collected between January-May 2011, on the Greek version of the MMAS-8 and Beliefs about Medicines Questionnaire (BMQ). Results: Scale’s reliability analysis revealed an overall Cronbach’s alpha of 0.753 and the corrected item to total correlations, were greater than 0.30 for each of the 8 items comprising the medication adherence scale, showing good internal consistency. Convergent validity was supported by a significant correlation between the present scale’s total score and the BMQ-Specific Necessity score (Spearman’s rho = 0.492, p < 0.001). Conclusion: The current study showed acceptable reliability and validity of the Greek version of the 8-item MMAS to measure adherence to medications for various chronic illnesses. The validated Greek version of the MMAS-8 can help towards understanding adherence barriers in Greece so as to develop effective strategies to increase adherence and reduce the costs.展开更多
文摘目的评价中文版8条目Morisky用药依从性问卷(MMAS-8)评估2型糖尿病患者用药依从性的信效度。方法纳入老年2型糖尿病患者127例,采用中文版MMAS-8及用药依从性视觉模拟评分(MA-VAS)评估,采用信度分析、相关分析、两样本t检验及因子分析评价量表信效度。结果中文版MMAS-8的Cronbachα系数为0.60,组内相关系数(ICC)为0.78。结构分析共提取3个公因子,共解释总方差的55.2%。中文版MMAS-8评分与MA-VAS评分相关(r=0.75,P<0.001)。血糖达标组〔糖化血红蛋白(Hb A1c)≤7%〕的中文版MMAS-8评分比血糖未达标组(Hb A1c>7%)高(7.1±1.0 vs 5.9±1.5,t=-4.31,P<0.001),两组间用药依从性差异显著(χ2=20.190,P<0.001)。结论中文版MMAS-8信效度较好,且简单、可靠、实用,可作为临床工具用于评估2型糖尿病患者的用药依从性。
文摘Objective: To validate a Greek version of the structured self-reported 8-item Morisky Medication Adherence Scale (MMAS-8) and determine its psychometric properties in patients with chronic illnesses. Methods: A cross-sectional survey was conducted in a small public hospital and a public health care centre, in a rural town in western Greece. The sample consisted of 100 patients with various chronic illnesses. Data were collected between January-May 2011, on the Greek version of the MMAS-8 and Beliefs about Medicines Questionnaire (BMQ). Results: Scale’s reliability analysis revealed an overall Cronbach’s alpha of 0.753 and the corrected item to total correlations, were greater than 0.30 for each of the 8 items comprising the medication adherence scale, showing good internal consistency. Convergent validity was supported by a significant correlation between the present scale’s total score and the BMQ-Specific Necessity score (Spearman’s rho = 0.492, p < 0.001). Conclusion: The current study showed acceptable reliability and validity of the Greek version of the 8-item MMAS to measure adherence to medications for various chronic illnesses. The validated Greek version of the MMAS-8 can help towards understanding adherence barriers in Greece so as to develop effective strategies to increase adherence and reduce the costs.
